TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29772657

Group type: EXPERIMENTAL
Intervention: Optimized Virgin Olive Oil (OVOO) (490 ppm of phenolic compounds and 86 ppm of triterpenes)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Virgin Olive Oil (VOO) (124 ppm of phenolic compounds and 86 ppm of triterpenes)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Functional Olive Oil (FOO) (487 ppm of phenolic compounds and 389 ppm of triterpenes)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Virgin Olive Oil (VOO) with at least 124 ppm of phenolic compounds
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: All three olive oils (VOO, OVOO, FOO)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Triterpenes
Number of subjects: 58
Study: 27400272

Group type: EXPERIMENTAL
Intervention: 80mg atorvastatin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24443442

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (DIPSS cohort)
Number of subjects: 100
Study: 22433175

Group type: EXPERIMENTAL
Intervention: Online geriatric assessment
Number of subjects: 270

Group type: COMPARATOR
Intervention: Live geriatric assessment
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Resource use data for online assessments
Number of subjects: 270

Group type: COMPARATOR
Intervention: Resource use data for live assessments
Number of subjects: 270
Study: 19958646

Group type: EXPERIMENTAL
Intervention: Magnesium isoglycyrrhizinate 100 mg once daily (group A)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Magnesium isoglycyrrhizinate 150 mg once daily (group B)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Compound glycyrrhizin 120 mg once daily (group C)
Number of subjects: 480
Study: 17938309

Group type: EXPERIMENTAL
Intervention: Swedish adjustable gastric band
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Lap-Band
Number of subjects: 400

Group type: COMPARATOR
Intervention: Both devices (Swedish adjustable gastric band and Lap-Band)
Number of subjects: 400
Study: 15727954

Group type: EXPERIMENTAL
Intervention: Normal ACTH - normal cortisol
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High ACTH - high cortisol
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High ACTH - low cortisol
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo and steroidogenic inhibitor
Number of subjects: 65
Study: 11990404

Group type: EXPERIMENTAL
Intervention: One additional daytime 2-L exchange (intervention group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no additional exchanges)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Increasing exchanges from 3 to 4 per day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Increasing exchanges from 4 to 5 per day
Number of subjects: 100
Study: 11429939

Group type: EXPERIMENTAL
Intervention: Brånemark implants
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IMZ implants
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ITI implants
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 8134073

Group type: EXPERIMENTAL
Intervention: Metoclopramide regimen (2 mg/kg IV every 2 hours x 3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ondansetron regimen (0.15 mg/kg IV every 4 hours x 3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but includes diphenhydramine, prochlorperazine, and lorazepam)
Number of subjects: 40
Study: 2643902

Group type: EXPERIMENTAL
Intervention: Budesonide (400 micrograms twice a day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31415305

Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AuraGain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: air-Q
Number of subjects: 0
Study: 28422388

Group type: EXPERIMENTAL
Intervention: Nature sounds
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Relaxation exercises
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control (silent rest)
Number of subjects: 159
Study: 25886090

Group type: EXPERIMENTAL
Intervention: Cetirizine plus ranitidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cetirizine plus placebo
Number of subjects: 32
Study: 24028597

Group type: EXPERIMENTAL
Intervention: GLUMA Desensitizer PowerGel
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Opalescence Boost PF 40% gel
Number of subjects: 46
Study: 21174144

Group type: EXPERIMENTAL
Intervention: H5N1 vaccine with AS03(A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: H5N1 vaccine without AS03(A)
Number of subjects: 50
Study: 19581353

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Salmeterol (SAL) 50 microg
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 microg
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone combination (SFC) (SAL 50 microg/FP 500 microg)
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: All treatments (Placebo, SAL, FP, SFC)
Number of subjects: 658
Study: 17356088

Group type: EXPERIMENTAL
Intervention: Herbst mandibular advancement splint (MAS) treatment for 1 year
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 16
Study: 15094948

Group type: EXPERIMENTAL
Intervention: Nutritional supplement with synbiotics (PS)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Nutritional supplement without synbiotics (P)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Fruit-flavored drink (D)
Number of subjects: 129
Study: 15604181

Group type: EXPERIMENTAL
Intervention: Standard strength static bipolar magnetic bracelet
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Weak magnetic bracelet
Number of subjects: 194

Group type: COMPARATOR
Intervention: Non‐magnetic (dummy) bracelet
Number of subjects: 194
Study: 11275616

Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate (NaP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 60
Study: 9256938

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Saquinavir
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Zidovudine and Saquinavir (combination)
Number of subjects: 38
Study: 8341892

Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3577640

Group type: EXPERIMENTAL
Intervention: Graduated compression elastic stockings
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no stockings)
Number of subjects: 20
Study: 31235428

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (E-LC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (D-LC)
Number of subjects: 52
Study: 29663492

Group type: EXPERIMENTAL
Intervention: 4% articaine with epinephrine (1:100,000)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 4% articaine without epinephrine
Number of subjects: 30
Study: 27526787

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 150
Study: 24630081

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 10 mg daily for 3 months
Number of subjects: 209

Group type: COMPARATOR
Intervention: Norethisterone acetate (NETA) 10 mg daily for 10 days (control)
Number of subjects: 209
Study: 24172250

Group type: EXPERIMENTAL
Intervention: Niños Sanos, Familia Sana intervention (multi-faceted including nutrition, physical activity, economic and art-community engagement)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison community engagement strategies
Number of subjects: 0
Study: 20720117

Group type: EXPERIMENTAL
Intervention: Reward-related visual features
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reward feedback response in anterior cingulate cortex
Number of subjects: 0
Study: 17924157

Group type: EXPERIMENTAL
Intervention: Orientation session led by a PSG technician
Number of subjects: 1481

Group type: COMPARATOR
Intervention: Control group (no orientation session)
Number of subjects: 1481
Study: 16640631

Group type: EXPERIMENTAL
Intervention: Practical Approach to Lung Health (PAL) guidelines
Number of subjects: 40
Study: 12807271

Group type: EXPERIMENTAL
Intervention: Intensive intervention group (24 GPs) involved in the development and implementation of clinical guidelines for acute respiratory infections.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Moderate intervention group (control group) received a brief educational event and distribution of guidelines.
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intensive intervention group (24 GPs)
Number of subjects: 54
Study: 10385495

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg daily for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 8682968

Group type: EXPERIMENTAL
Intervention: 2% minoxidil topical solution
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 1843527

Group type: EXPERIMENTAL
Intervention: Tokens produced by different speakers presented blocked by speaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulations of presentation type (blocked vs. randomized)
Number of subjects: 0
Study: 6131682

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 64

Group type: COMPARATOR
Intervention: Vecuronium (3 times ED90)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Atracurium (3 times ED90)
Number of subjects: 64
Study: 31307412

Group type: EXPERIMENTAL
Intervention: ML program (10-week group sessions focusing on evidence-based parenting practices followed by the MINISTOP application for 6 months)
Number of subjects: 300
Study: 28554160

Group type: EXPERIMENTAL
Intervention: Reward arm (n=107) with a payment of S$165.00 and potential rewards of up to S$660 for meeting goals.
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control arm (n=54) receiving the same weight loss program without rewards.
Number of subjects: 161
Study: 25888863

Group type: EXPERIMENTAL
Intervention: Individually generate an extra written question on disease mechanisms during small-group work
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control group (no extra question generation)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Male students in the intervention group
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Female students in the intervention group
Number of subjects: 459
Study: 23506324

Group type: EXPERIMENTAL
Intervention: Use of a vest during medication administration
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Environmental factors and distractions
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Education sessions with health professionals and patients
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Changes in work design
Number of subjects: 140
Study: 21153900

Group type: EXPERIMENTAL
Intervention: Dietary group (DG) receiving daily for 30 months, 1,200 mg of calcium and 7.5 μg of vitamin D(3) for the first 12 months, increasing to 22.5 μg for the remaining 18 months through fortified dairy products
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study: 19618698

Group type: EXPERIMENTAL
Intervention: Dual-target condition (caregiver intervention + care recipient treatment)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Caregiver-only condition
Number of subjects: 173

Group type: COMPARATOR
Intervention: Information-only control condition
Number of subjects: 173
Study: 17559386

Group type: EXPERIMENTAL
Intervention: Simulator-augmented training (SAT) group
Number of subjects: 8

Group type: COMPARATOR
Intervention: Patient-based training (PBT) group
Number of subjects: 8
Study: 15077288

Group type: EXPERIMENTAL
Intervention: RAPIT program (high-intensity weight-bearing exercise)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Usual care physical therapy
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: RAPIT program
Number of subjects: 309
Study: 12153607

Group type: EXPERIMENTAL
Intervention: Ghrelin (1.0 micro g/kg i.v. at 0 min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: GHRH (1.0 micro g/kg i.v. at 0 min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: OGTT (100 g oral glucose at -45 min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Li-He (Intralipid 10% 250 ml + heparin 2500 U i.v. from -30 to +120 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ARG (0.5 g/kg infused from 0 to +30 min)
Number of subjects: 6
Study: 9794328

Group type: EXPERIMENTAL
Intervention: Vista 350 telephone for 6 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional methods for recording home monitoring data
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Vista 350 telephone
Number of subjects: 35
Study: 7890055

Group type: COMPARATOR
Intervention: Conventional regimen of urinary human FSH using a conventional stepwise protocol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chronic low-dose regimen of urinary human FSH or recombinant human FSH
Number of subjects: 50
Study: 2240937

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Cefoperazone
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Piperacillin and Metronidazole
Number of subjects: 177
Study: 37853

Group type: EXPERIMENTAL
Intervention: Mefenorex (40 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fenetylline (50 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7082858

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum administered intravenously on day 15 of the cytostatic cycle (group I)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum administered intravenously on day 1 of the cytostatic cycle (group II)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No administration of Corynebacterium parvum (group III)
Number of subjects: 18
Study: 31398275

Group type: EXPERIMENTAL
Intervention: Cyclic peptide ligands selected from a randomized 6-mer library using a cysteine-AcrK linker.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linear peptide counterparts (implied control).
Number of subjects: 0
Study: 29464691

Group type: EXPERIMENTAL
Intervention: Fi O2 0.40
Number of subjects: 65

Group type: COMPARATOR
Intervention: Fi O2 0.70
Number of subjects: 65
Study: 26903214

Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields (PEMFs)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 24628390

Group type: EXPERIMENTAL
Intervention: 5 mg/d folate supplements
Number of subjects: 69
Study: 22713999

Group type: EXPERIMENTAL
Intervention: Acetaminophen plus ibuprofen (AcIBU)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Acetaminophen plus codeine plus caffeine (T3)
Number of subjects: 141
Study: 20555373

Group type: EXPERIMENTAL
Intervention: Fish-oil supplement (approximately 1 g EPA and DHA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17907479

Group type: EXPERIMENTAL
Intervention: Ozone application for 10 seconds on caries lesions
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Ozone treatment and a root sealant applied to root caries lesions
Number of subjects: 79

Group type: COMPARATOR
Intervention: Ozone only group
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sealant only group
Number of subjects: 79
Study: 15316852

Group type: EXPERIMENTAL
Intervention: Acupuncture using laser needles (optical stimulation method)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 18
Study: 11513907

Group type: EXPERIMENTAL
Intervention: WHO short-course chemotherapy
Number of subjects: 646

Group type: COMPARATOR
Intervention: Russian tuberculosis treatment
Number of subjects: 646
Study: 9051390

Group type: EXPERIMENTAL
Intervention: rhIGF‐I (80 mcg/kg s.c.)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 8329005

Group type: EXPERIMENTAL
Intervention: Standard meal
Number of subjects: 8
Study: 3570421

Group type: EXPERIMENTAL
Intervention: Potassium chloride, 120 mEq/day
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 29121961

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (physical exercise and cognitive behavioral techniques)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Pain education program (treatment as usual)
Number of subjects: 160
Study: 26099226

Group type: EXPERIMENTAL
Intervention: Anti-Thymocyte Globulins (ATG)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Basiliximab
Number of subjects: 384
Study: 24318038

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (0.3 g/kg for 7 days)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 23
Study: 21374068

Group type: EXPERIMENTAL
Intervention: Arzoxifene 20 mg/day
Number of subjects: 320

Group type: COMPARATOR
Intervention: Raloxifene 60 mg/day
Number of subjects: 320
Study: 18979504

Group type: EXPERIMENTAL
Intervention: Beta-glucan muesli (4.8 g oat beta-glucan)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination muesli (4.8 g oat beta-glucan plus 1.4 g stanol as PSE)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control muesli (4.8 g control fiber)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Beta-glucan muesli and Combination muesli
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: PSE (plant stanol esters)
Number of subjects: 42
Study: 17456125

Group type: EXPERIMENTAL
Intervention: Nurse-CHW team intervention
Number of subjects: 530

Group type: COMPARATOR
Intervention: Standard community care (enhanced prenatal services with nurse home visiting)
Number of subjects: 530
Study: 14738235

Group type: EXPERIMENTAL
Intervention: DNK333 (100 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11321379

Group type: EXPERIMENTAL
Intervention: Experimental formula based on acid whey without glycomacropeptide (GMP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sweet whey formula with glycomacropeptide (GMP)
Number of subjects: 14
Study: 9661678

Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) at 2.5 micrograms/kg/hr
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) at 4.0 micrograms/kg/hr
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7923825

Group type: COMPARATOR
Intervention: 5% saline infusion (0.06 ml/kg/h)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 20% mannitol infusion (0.07 ml/kg/h)
Number of subjects: 8
Study: 2894902

Group type: EXPERIMENTAL
Intervention: Atracurium (0.4 mg.kg‐1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: d-tubocurarine (0.8 mg.kg‐1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pancuronium (0.12 mg.kg‐1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.07 mg.kg‐1)
Number of subjects: 67
Study: 30370837

Group type: EXPERIMENTAL
Intervention: Modified 8-week Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 110
Study: 28155109

Group type: EXPERIMENTAL
Intervention: Peer‐based Group Lifestyle Balance (PGLB) intervention
Number of subjects: 14
Study: 25675317

Group type: EXPERIMENTAL
Intervention: Aftercare treatment (2-4 interview contacts via telephone or face-to-face within the first 3 months after discharge)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 201
Study: 23866800

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 61
Study: 21478141

Group type: EXPERIMENTAL
Intervention: High-voltage stimulation (HVS) with drug therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ultrasound with drug therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with drug therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Compression stockings with drug therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Drug therapy only
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Conservative HVS with drug therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Conservative ultrasound with drug therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Conservative LLLT with drug therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Conservative compression with drug therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conservative drug therapy only
Number of subjects: 40
Study: 19515730

Group type: EXPERIMENTAL
Intervention: HD-FPV/RTV (1400 mg/100 mg twice daily)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: FPV/LPV/RTV (1400 mg/533 mg/133 mg twice daily)
Number of subjects: 74

Group type: COMPARATOR
Intervention: STD-FPV/RTV (700 mg/100 mg twice daily)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HD-FPV/RTV
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: FPV/LPV/RTV
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HD-FPV/RTV and FPV/LPV/RTV
Number of subjects: 74
Study: 17368232

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham feedback therapy
Number of subjects: 77
Study: 14999111

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (conjugated equine estrogens 0.625 mg/day plus medroxyprogesterone acetate 2.5 mg/day)
Number of subjects: 16608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin
Number of subjects: 16608

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin with antecedent vaginal bleeding
Number of subjects: 16608
Study: 11525858

Group type: EXPERIMENTAL
Intervention: Acticoat
Number of subjects: 15

Group type: COMPARATOR
Intervention: Allevyn
Number of subjects: 15